Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AGverified

SANN.SW

Price:

$9.36

Market Cap:

$113.31M

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes vamorolone, which is being developed as treatments for Duchenne muscular dystrophy (DMD). Its clinical stage pipeline also comprises lonodelestat (POL6014) to treat cystic fibrosis and other neutrophilic pulmonary diseases, as well as omigapil that treats congenital muscular dystrophies. The company also out-licenses outside North America and France rights to its approved product, Raxone (...[Read more]

Industry

Biotechnology

IPO Date

2006-11-03

Stock Exchange

SIX

Ticker

SANN.SW

The Current Ratio as of September 2024 (TTM) for Santhera Pharmaceuticals Holding AG (SANN.SW) is 0.78

According to Santhera Pharmaceuticals Holding AG’s latest financial reports and current stock price. The company's current Current Ratio is 0.78. This represents a change of 69.85% compared to the average of 0.46 of the last 4 quarters.

Santhera Pharmaceuticals Holding AG (SANN.SW) Historical Current Ratio (quarterly & annually)

How has SANN.SW Current Ratio performed in the past?

The mean historical Current Ratio of Santhera Pharmaceuticals Holding AG over the last ten years is 3.66. The current 0.78 Current Ratio has changed 2.04% with respect to the historical average. Over the past ten years (40 quarters), SANN.SW's Current Ratio was at its highest in in the September 2015 quarter at 12.08. The Current Ratio was at its lowest in in the September 2017 quarter at 0.

Quarterly (TTM)
Annual

Average

3.66

Median

2.12

Minimum

0.06

Maximum

12.08

Santhera Pharmaceuticals Holding AG (SANN.SW) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Santhera Pharmaceuticals Holding AG Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.16%

Maximum Annual Current Ratio = 12.08

Minimum Annual Increase = -91.75%

Minimum Annual Current Ratio = 0.06

Quarterly (TTM)
Annual
YearCurrent RatioChange
20230.781.16%
20220.06-91.75%
20210.7523.29%
20200.61-70.34%
20192.06-5.97%
20182.19-62.69%
20175.86-3.61%
20166.08-49.69%
201512.0897.35%
20146.1285.58%

Santhera Pharmaceuticals Holding AG (SANN.SW) Average Current Ratio

How has SANN.SW Current Ratio performed in the past?

The current Current Ratio of Santhera Pharmaceuticals Holding AG (SANN.SW) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0.53

5-year avg

0.85

10-year avg

3.66

Santhera Pharmaceuticals Holding AG (SANN.SW) Current Ratio vs. Peers

How is SANN.SW’s Current Ratio compared to its peers?

Santhera Pharmaceuticals Holding AG’s Current Ratio is less than Basilea Pharmaceutica AG (4.10), less than Idorsia Ltd (0.92), greater than Newron Pharmaceuticals S.p.A. (0.68), less than Evolva Holding SA (3.65), less than Molecular Partners AG (14.58),

Build a custom stock screener for Santhera Pharmaceuticals Holding AG (SANN.SW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Santhera Pharmaceuticals Holding AG using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Santhera Pharmaceuticals Holding AG (SANN.SW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Santhera Pharmaceuticals Holding AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Santhera Pharmaceuticals Holding AG's Current Ratio?

How is the Current Ratio calculated for Santhera Pharmaceuticals Holding AG (SANN.SW)?

What is the highest Current Ratio for Santhera Pharmaceuticals Holding AG (SANN.SW)?

What is the 3-year average Current Ratio for Santhera Pharmaceuticals Holding AG (SANN.SW)?

What is the 5-year average Current Ratio for Santhera Pharmaceuticals Holding AG (SANN.SW)?

How does the current Current Ratio for Santhera Pharmaceuticals Holding AG (SANN.SW) compare to its historical average?